Cmax is out of the range [Study As­sess­ment]

posted by jag009  – NJ, 2018-08-02 19:56 (2451 d 04:31 ago) – Posting: # 19128
Views: 4,843

Hi,

❝ We recently conducted a BE trial. It was a classical 2-period, 2-sequence study of a drug that consists of a combination of two active substances. Unfortunately, results one of analytes, a parent drug, fell sightly outside of the 80-125% range, below 80% for Cmax. CV was below 30% and post-hoc power was less than 80% for this analyte...


Sorry, there is no way for you to argue.
John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,709 registered users;
27 visitors (0 registered, 27 guests [including 7 identified bots]).
Forum time: 00:28 CEST (Europe/Vienna)

Do not worry about your difficulties in mathematics.
I can assure you mine are still greater.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5